Delivery Order SPE2DB22D1103-SPE2DB25FH1E8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $27,354.93 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) on August 28, 2025, with an ultimate completion date of August 29, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal vaccine critical to military and federal healthcare immunization...
- The Defense Logistics Agency awarded a delivery order valued at $8,453.56 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5ML) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used for immunization against pneumococcal...
- The Defense Logistics Agency awarded a delivery order valued at $24,506.55 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) on July 24, 2025, with an ultimate completion date of July 25, 2025. This delivery order represents a competitive, firm fixed-price award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used for immunization against pneumococcal disease,...
- The Defense Logistics Agency awarded a delivery order valued at approximately $25,018 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine in 0.5mL syringes. This non-set-aside, competitively awarded contract reflects a firm fixed-price arrangement with an ultimate completion date of August 28, 2025. The delivery order was executed on August 27, 2025, with performance to be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $194,207.50 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5ml) under a firm fixed price contract. The award, issued on July 31, 2025, with completion scheduled for August 1, 2025, represents a direct procurement of this pneumococcal vaccine product to be performed at the vendor's Conshohocken, Pennsylvania facility. This delivery order was competitively awarded with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) valued at $6,760.81 under a firm fixed-price arrangement. This non-set-aside delivery order was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease and...
- The Defense Logistics Agency awarded a delivery order valued at $4,901.31 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is being performed at the contractor's Conshohocken, Pennsylvania location. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a $14,078.16 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on July 30, 2025, with a completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease across multiple age groups, making it...
- The Defense Logistics Agency awarded a delivery order valued at $23,429.21 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine in 0.5mL syringes. This non-competitive, firm fixed-price delivery order was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine procurement under the company's larger relationship with the...
- The Defense Logistics Agency awarded a $12,261.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a non-set-aside contract, competitively awarded to the pharmaceutical distributor's Corporate Office division located in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease in eligible populations, representing...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FH1E8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,901.31 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) on August 28, 2025, with completion scheduled for August 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to protect against pneumococcal disease and represents part of the broader medical supply procurement needs of the Department of Defense. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including vaccines, medications, syringes, and related medical commodities across multiple therapeutic domains. AmerisourceBergen's position as a major pharmaceutical distributor and critical federal medical vendor is reflected in its extensive contract portfolio with the DLA and its demonstrated capability to fulfill federal procurement requirements through open competition across varying order values and medical product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 8/28/25 |